Bayesian Clinical Trials

被引：0
作者：
Clark, Jennifer [1 ]
Muhlemann, Natalia [2 ]
Ionan, Alexei [1 ]
机构：
[1] FDA, CDER Off Biostat, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
[2] Cytel, Cambridge, MA USA
来源：
THERAPEUTIC INNOVATION & REGULATORY SCIENCE | 2023年 / 57卷 / 03期
关键词：
D O I：
10.1007/s43441-023-00498-1
中图分类号：
R-058 [];
学科分类号：
摘要：
The following is an introduction from the guest editors for the Bayesian Clinical Trials series.
引用
收藏
页码：399 / 400
页数：2
相关论文
共 8 条
  • [1] Why are There not More Bayesian Clinical Trials? Ability to Interpret Bayesian and Conventional Statistics Among Medical Researchers
    Bray, Ross
    Hartley, Andrew
    Wenkert, Deborah
    Muehlemann, Natalia
    Natanegara, Fanni
    Harrell, Frank E.
    Wang, Fei
    Clark, Jennifer
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (03) : 426 - 435
  • [2] Campbell G, THER INNOV REGUL SCI
  • [3] Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development
    Clark, Jennifer
    Muhlemann, Natalia
    Natanegara, Fanni
    Hartley, Andrew
    Wenkert, Deborah
    Wang, Fei
    Harrell, Frank E., Jr.
    Bray, Ross
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (03) : 417 - 425
  • [4] Garczareket U, THER INNOV REGUL SCI
  • [5] The Bayesian Design of Adaptive Clinical Trials
    Giovagnoli, Alessandra
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (02) : 1 - 15
  • [6] Bayesian Methods in Human Drug and Biological Products Development in CDER and CBER
    Ionan, Alexei C. C.
    Clark, Jennifer
    Travis, James
    Amatya, Anup
    Scott, John
    Smith, James P. P.
    Chattopadhyay, Somesh
    Salerno, Mary Jo
    Rothmann, Mark
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (03) : 436 - 444
  • [7] Muhlemann N, THER INNOV REGUL SCI
  • [8] Spiegelhalter DJ., 2004, BAYESIAN APPROACHES
1